Concepedia

Phillip Liu

PL

Statistics

Publications

14

Citations

1.6K

H-Index

14

Active since

1985

Affiliations

Incyte (United States)(Current)

Experimental Station

The University of Texas MD Anderson Cancer Center

Phillip Liu is an author at Incyte (United States) specializing in medicine, cell biology, and natural sciences.

ORCID

Top concepts

Publications per year

1985–2024

14

Publications

14

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

Alfonso Quintás‐Cardama, Kris Vaddi, Phillip Liu et al. · Blood · 2010 · 813 citations

Rhesus expression in a green alga is regulated by CO <sub>2</sub>

Eric Soupène, Natalie D. King, Eithne Feild et al. · Proceedings of the National Academy of Sciences · 2002 · 144 citations · Full text

The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke’s Encephalopathy

Qiang Zhang, Yan Zhang, Sharon Diamond et al. · Drug Metabolism and Disposition · 2014 · 117 citations

The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer

Andrew J. Wilson, Matthew C. Stubbs, Phillip Liu et al. · Gynecologic Oncology · 2018 · 109 citations · Full text

, , +7

Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics

Andrew P. Combs, Eddy W. Yue, Michael J. Bower et al. · Journal of Medicinal Chemistry · 2005 · 101 citations · Full text

, , +13

1–5 of 14